New blood thinner combo may be safer after valve replacement
NCT ID NCT02817789
First seen May 14, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study tested whether a single blood thinner (ticagrelor) is safer than the standard two-drug combination after a minimally invasive heart valve replacement (TAVI) for aortic stenosis. 50 older adults participated, and researchers tracked complications like bleeding, stroke, and kidney injury within 30 days. The goal was to find the best anti-clotting approach to reduce risks after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM
Marseille, 13005, France
-
APHP
Paris, 75013, France
-
CHRU de Lille
Lille, 59037, France
-
CHRU de Nîmes
Nîmes, 30029, France
-
CHU de Bordeaux
Pessac, 33604, France
Conditions
Explore the condition pages connected to this study.